These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Nondevelopment of resistance by bacteria during hospital use of povidone-iodine. Lanker Klossner B, Widmer HR, Frey F. Dermatology; 1997; 195 Suppl 2():10-3. PubMed ID: 9403249 [Abstract] [Full Text] [Related]
27. Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Reimer K, Wichelhaus TA, Schäfer V, Rudolph P, Kramer A, Wutzler P, Ganzer D, Fleischer W. Dermatology; 2002; 204 Suppl 1():114-20. PubMed ID: 12011534 [Abstract] [Full Text] [Related]
28. Antiseptic efficacy of local disinfecting povidone-iodine (Betadine) therapy in chronic wounds of lymphedematous patients. Daróczy J. Dermatology; 2002; 204 Suppl 1():75-8. PubMed ID: 12011526 [Abstract] [Full Text] [Related]
29. New successful treatment with disinfectant for atopic dermatitis. Sugimoto K, Kuroki H, Kanazawa M, Kurosaki T, Abe H, Takahashi Y, Ishiwada N, Nezu Y, Hoshioka A, Toba T. Dermatology; 1997; 195 Suppl 2():62-8. PubMed ID: 9403258 [Abstract] [Full Text] [Related]
30. Physicochemical characterization of tretinoin tocoferil emulsion and povidone-iodine sugar ointment blend developed for improved regulation of wound moisture. Noda Y, Saito M, Watanabe K, Sanagawa A, Sobajima Y, Fujii S. Chem Pharm Bull (Tokyo); 2013; 61(7):700-5. PubMed ID: 23676566 [Abstract] [Full Text] [Related]
31. Evaluation of antiseptics by the modified phenol coefficient method: sensitivity of methicillin-resistant Staphylococcus aureus. Sasatsu M, Shimizu K, Noguchi N, Kono M. Biol Pharm Bull; 1994 Jan; 17(1):136-8. PubMed ID: 8148802 [Abstract] [Full Text] [Related]
35. Comparison of bactericidal activities of various disinfectants against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus. Yasuda T, Yoshimura S, Katsuno Y, Takada H, Ito M, Takahashi M, Yahazaki F, Iriyama J, Ishigo S, Asano Y. Postgrad Med J; 1993 Jan; 69 Suppl 3():S66-9. PubMed ID: 8290461 [Abstract] [Full Text] [Related]
36. A randomised trial of povidone-iodine to reduce visual impairment from corneal ulcers in rural Nepal. Katz J, Khatry SK, Thapa MD, Schein OD, Kimbrough Pradhan E, LeClerq SC, West KP. Br J Ophthalmol; 2004 Dec; 88(12):1487-92. PubMed ID: 15548795 [Abstract] [Full Text] [Related]
37. New aspects of the tolerance of the antiseptic povidone-iodine in different ex vivo models. Kramer A, Below H, Behrens-Baumann W, Müller G, Rudolph P, Reimer K. Dermatology; 2002 Dec; 204 Suppl 1():86-91. PubMed ID: 12011528 [Abstract] [Full Text] [Related]
38. Comparison of free and bound iodine and iodide species as a function of the dilution of three commercial povidone-iodine formulations and their microbicidal activity. Atemnkeng MA, Plaizier-Vercammen J, Schuermans A. Int J Pharm; 2006 Jul 24; 317(2):161-6. PubMed ID: 16650702 [Abstract] [Full Text] [Related]
39. Ex vivo evaluation of the stability, safety and antibacterial efficacy of an extemporaneous povidone-iodine preparation for ophthalmic applications. Lee S, Khun D, Kumarasinghe GL, De Zoysa GH, Sarojini V, Vellara HR, Rupenthal ID, Thakur SS. Clin Exp Optom; 2019 Nov 24; 102(6):583-589. PubMed ID: 30924199 [Abstract] [Full Text] [Related]